Effect of XXXX on the clinical and immunologic responses to oral vaccine of @entity2127 .

@entity1707 @entity28962 @entity294 @entity7305 @entity2127 @entity465 @entity12870
Conventionally raised crossbred Hampshire @entity1707 were vaccinated orally with attenuated @entity2127 in combination with an anthelmintic, @entity7305 or @entity28962 . @entity1707 in group I (n = 9) were treated with @entity7305 and vaccinated with attenuated @entity2127 and those in group II (n = 9) were treated with @entity7305 and permitted to commingle (contact exposure) with group I. @entity1707 in group III (n = 9) were vaccinated in a similar manner and were treated with @entity28962 . @entity1707 in group IV (n = 9) were treated with @entity28962 and permitted to commingle with group III. Control @entity1707 (group V; n = 9) were not given any anthelmintic, nor were they vaccinated; they were housed separately. During the 8-week interval between vaccination and challenge inoculation, 4 total days and 8 total days of @entity294 were observed in @entity1707 in groups I and II, respectively. Likewise, 5 total days and 10 total days of @entity294 were seen in groups III and IV, respectively. In all groups, the @entity1707 tended to shed the organism in their feces after they were vaccinated or challenge inoculated, as determined by a @entity465 ( @entity465 ) and @entity12870 ( @entity12870 ). Overall mean shedding patterns of 5.5% and 24.5% identified by @entity12870 and @entity465 , respectively, were seen in the 2 @entity7305 -treated groups (I and II). In contrast, mean shedding patterns of 4% and 18% of the isolation attempts were detected by @entity12870 and @entity465 , respectively, in the 2 @entity28962 -treated groups. @entity294 and shedding of @entity2127 in the controls (group V) did not occur.(ABSTRACT TRUNCATED AT 250 WORDS)
